Area of research
Genetics · Molecular Biology
Research interest
Research interests include Glioma Diagnosis and Treatment, Neurogenetic and Muscular Disorders Research, Amyloidosis: Diagnosis, Treatment, Outcomes, and Peripheral Nerve Disorders.
Efficacy of Hand Cooling and Compression in Preventing Taxane-Induced Neuropathy
Long-Term Dynamics of CSF and Serum Neurofilament Light Chain in Adult Patients With 5q Spinal Muscular Atrophy Treated With Nusinersen
Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen
Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen – a multicenter observational study
Peripheral Nerve Involvement in Friedreich's Ataxia Characterized by Quantitative Magnetic Resonance Neurography
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System Glioma
Evolution of peripheral nerve changes in early multiple sclerosis—a longitudinal MR neurography study
Interpretation of Elevated Baseline Concentrations and Serial Changes of High-Sensitivity Cardiac Troponin T in Confirmed Muscular Dystrophies
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy
Effect of Eplontersen on Cardiac Structure and Function in Patients With Hereditary Transthyretin Amyloidosis
Evaluation of risdiplam efficacy in 5q spinal muscular atrophy: A systematic comparison of electrophysiologic with clinical outcome measures
Microstructural changes of peripheral nerves in early multiple sclerosis: A prospective magnetic resonance neurography study
Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study
Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen
Adult‐Onset Neurodegeneration in Nucleotide Excision Repair Disorders (<scp>NERD<sub>ND</sub></scp>): Time to Move Beyond the Skin
Quantitative magnetic resonance neurographic characterization of peripheral nerve involvement in manifest and pre‐ataxic spinocerebellar ataxia type 3
1552O Chemotherapy-induced peripheral neuropathy (CIPN) prevention trial evaluating the efficacy of hand-cooling and compression in patients undergoing taxan-based (neo-)adjuvant chemotherapy for primary breast cancer: First results of the prospective, randomized POLAR trial
Preventive effect of sensorimotor exercise and resistance training on chemotherapy-induced peripheral neuropathy: a randomised-controlled trial
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen
Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment
Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control
Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study
Cerebrospinal fluid proteomic profiling in nusinersen‐treated patients with spinal muscular atrophy
Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature
Out of balance – Postural control in cancer patients before and after neurotoxic chemotherapy
Hereditäre Transthyretinamyloidose (ATTRv-Amyloidose)
Quantitative MR neurography biomarkers in 5q-linked spinal muscular atrophy
Peripheral nerve involvement in multiple sclerosis: Demonstration by magnetic resonance neurography
Sural nerve injury in familial amyloid polyneuropathy